» Articles » PMID: 35396078

American Association of Clinical Endocrinology Disease State Clinical Review: The Clinical Utility of Minimally Invasive Interventional Procedures in the Management of Benign and Malignant Thyroid Lesions

Overview
Journal Endocr Pract
Specialty Endocrinology
Date 2022 Apr 9
PMID 35396078
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this disease state clinical review is to provide clinicians with a summary of the nonsurgical, minimally invasive approaches to managing thyroid nodules/malignancy, including their indications, efficacy, side effects, and outcomes.

Methods: A literature search was conducted using PubMed and appropriate key words. Relevant publications on minimally invasive thyroid techniques were used to create this clinical review.

Results: Minimally invasive thyroid techniques are effective and safe when performed by experienced centers. To date, percutaneous ethanol injection therapy is recommended for recurrent benign thyroid cysts. Both ultrasound-guided laser and radiofrequency ablation can be safely used for symptomatic solid nodules, both toxic and nontoxic. Microwave ablation and high-intensity focused ultrasound are newer approaches that need further clinical evaluation. Despite limited data, encouraging results suggest that minimally invasive techniques can also be used in small-size primary and locally recurrent thyroid cancer.

Conclusion: Surgery and radioiodine treatment remain the conventional and established treatments for nodular goiters. However, the new image-guided minimally invasive approaches appear safe and effective alternatives when used appropriately and by trained professionals to treat symptomatic or enlarging thyroid masses.

Citing Articles

Radiofrequency Ablation for Locoregional Structural Incomplete Response in Differentiated Thyroid Cancer: Initial Experience in Greece.

Simeakis G, Kapama A, Paparodis R, Gkousis P, Koursaros P, Kokkinis C Biomedicines. 2025; 13(2).

PMID: 40002668 PMC: 11852475. DOI: 10.3390/biomedicines13020255.


Microwave ablation for small papillary thyroid carcinomas: clinical outcomes and thyroid function preservation.

Zhao L, Peng X, Xiong J, Zhu Y, Song M Endocr Connect. 2025; 14(4).

PMID: 39952234 PMC: 11896648. DOI: 10.1530/EC-24-0628.


Outcomes of Radiofrequency Ablation for Autonomously Functioning Thyroid Adenomas-Mayo Clinic Experience.

Dhanasekaran M, Schmitz J, Castro M, Rajwani A, Lee R, Hamadi D J Endocr Soc. 2024; 8(12):bvae175.

PMID: 39502476 PMC: 11535713. DOI: 10.1210/jendso/bvae175.


Efficacy of echolaser smart interface-guided laser ablation in volume reduction of symptomatic benign thyroid nodules.

Malik I, Mitchell J, Thomas J Front Endocrinol (Lausanne). 2024; 15:1402522.

PMID: 39444453 PMC: 11496115. DOI: 10.3389/fendo.2024.1402522.


Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management.

Chan W, Chiang P, Lin A, Chang Y, Lin W Ultrasonography. 2024; 43(6):395-406.

PMID: 39397446 PMC: 11532522. DOI: 10.14366/usg.24083.